Format

Send to:

Choose Destination
See comment in PubMed Commons below
Nat Rev Cancer. 2010 Mar;10(3):165-80. doi: 10.1038/nrc2806.

Eph receptors and ephrins in cancer: bidirectional signalling and beyond.

Author information

  • 1Sanford-Burnham Medical Research Institute, La Jolla, CA 92037, USA. elenap@burnham.org

Abstract

The Eph receptor tyrosine kinases and their ephrin ligands have intriguing expression patterns in cancer cells and tumour blood vessels, which suggest important roles for their bidirectional signals in many aspects of cancer development and progression. Eph gene mutations probably also contribute to cancer pathogenesis. Eph receptors and ephrins have been shown to affect the growth, migration and invasion of cancer cells in culture as well as tumour growth, invasiveness, angiogenesis and metastasis in vivo. However, Eph signalling activities in cancer seem to be complex, and are characterized by puzzling dichotomies. Nevertheless, the Eph receptors are promising new therapeutic targets in cancer.

PMID:
20179713
[PubMed - indexed for MEDLINE]
PMCID:
PMC2921274
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Nature Publishing Group Icon for PubMed Central
    Loading ...
    Write to the Help Desk